"Existing risk prediction models use genetic and nongenetic risk factors to provide an estimate of a woman’s breast cancer risk and/or the likelihood that she has a BRCA1 or BRCA2 mutation."
➡️Read more in @DrGeunwonK's new @JBI_SBI paper:
https://t.co/cUv6lYlXjD
@DrJordanaP DDx: given the patient age and hyperechoic appearance of the mass on ultrasound, I think it is PASH. Since the focal asymmetry has associated non mass enhancement, it should go for biopsy. Probably under ultrasound, but stereo could work too. So, BIRADS 4A.